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To the Editor: Amitraz is an agricultural insecticide and veterinary 
pesticide used to treat ectoparasite infestations in animals. It has 
alpha-2-adrenergic agonist effects and inhibits monoamine oxidase. 
It is available in South Africa in concentrations of 12.5% and 
25%, usually dissolved in xylene or tetrachloroethylene, which 
may contribute to CNS depression in poisoned patients. Poisoning 
may be accidental or deliberate.1,2 Patients present with nausea, 
vomiting, bradycardia and either miosis or mydriasis, which may 
result in misdiagnosis as organophosphate or carbamate poisoning. 
Evidence for poisoning with these substances is supported by reduced 
red blood cell acetylcholinesterase or serum pseudocholinesterase 
levels; however, there is no readily available diagnostic test for 
amitraz poisoning. Reduced consciousness, respiratory depression 
and hyperglycaemia may occur in amitraz poisoning,3 while excessive 
salivation, incontinence, or muscle fasciculations are unlikely. A 
good outcome is usually observed with adequate supportive care.4,5 
Prompt recognition is important in deeply unconscious patients with 
pupillary changes, hypotension and respiratory depression.
Amitraz, its metabolites or solvents may contribute to a 
characteristic ‘mothball-like’ or ‘dry-cleaning’ odour in the poisoned 
patient, which is often particularly noticeable on endotracheal 
suctioning. Disagreement among clinicians about whether this smell 
is distinguishable from the odour of organophosphates includes 
dismissal of the odour as ‘just another chemical smell’.
If the odour can be learnt and recognised, a safely stored reference 
sample could be made available for bedside comparison. Due to 
clinical staff turnover and the rarity of this poisoning, training to 
recognise the odour and an assessment of diagnostic consistency 
is unrealistic; therefore, a pragmatic trial was planned to assess the 
feasibility of a ‘sniff and compare’ technique. 
Aim
To determine whether the odour of amitraz is sufficiently characteristic 
to be useful in differentiating amitraz from organophosphate 
solutions during blinded olfaction. 
Methods
The study was conducted at the East London Hospital Complex, 
consisting of both an urban and peri-urban hospital in the Eastern 
Cape. Volunteer subjects were pharmacists, doctors or nurses 
employed in the complex. Exclusion criteria included reported 
pregnancy and failure to provide written informed consent. The 
sample size (N=23) was based on an estimated sensitivity and 
specificity of 90% with a lower confidence interval (CI) of 70%. In 
the learning phase of the study, the subjects were introduced to the 
odours of amitraz, organophosphate and a control (distilled water) 
from labelled opaque glass bottles containing one undiluted drop 
of each ingredient on a cotton wool pledget. The bottle tops were 
replaced by foil with several small perforations. In the testing phase, 
individual subjects were taken to a separate room where coded 
opaque bottles containing the 3 samples were proffered according 
to a random computer-generated sequence. The subjects were asked 
to identify the content of each bottle by smell alone. Information 
recorded included gender, level of training, number of years in 
practice, and whether the subject reported a blocked nose. 
Ethical and safety issues
The protocol was approved by the East London Hospital Complex 
Institutional Review Board. A fume hood was used to prepare the 
samples. Subjects were exposed to the samples twice, and did not 
make physical contact with the chemicals. Both phases of the study 
occurred in well-ventilated areas.
Results
There were 23 subjects, 11 of whom were female. The mean 
number of years in practice was 12 (standard deviation 11.3). 
Subjects included 12 medical officers (52%), 6 medical interns 
(26%), 3 consultants, 1 pharmacist, and 1 ICU-trained professional 
nurse (22%). 
The sensitivity and specificity to detect amitraz compared with 
organophosphate were both 83% (95% CI 63 - 93%); 4 out of 23 
subjects were unable to distinguish between the two. One subject 
suffered from chronic sinusitis; if excluded from the data set, the 
resultant sensitivity and specificity were both 86% (95% CI 67 - 
95%). All subjects were able to distinguish between the control 
(water) and the test chemicals.
Discussion
Although amitraz poisoning is often initially misdiagnosed as 
organophosphate poisoning, the management thereof is different, 
and there is currently no readily available diagnostic test for this 
toxin. This study demonstrated the feasibility of using smell to 
identify amitraz, but is not proof of bedside value. The performance 
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The initial clinical presentation of amitraz and organophosphate 
poisoning may be similar. Reduced serum pseudocholinesterase 
supports a diagnosis of organophosphate toxicity, but there is no 
similar laboratory test for amitraz poisoning. A ‘mothball-like’ 
odour associated with poisoned patients may have diagnostic 
potential. In a blinded controlled trial, 83% (95% confidence 
interval, 63 - 93%) of 23 healthcare workers were able to distinguish 
between the odours of amitraz and organophosphates. Awareness 
of this simple component of bedside examination may allow earlier 
recognition of this potentially fatal poisoning.
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of clinicians may improve with repeated exposure and testing with 
feedback; however, this may run the risk of sensory habituation, and 
deviate from the likely real-world application of the technique.
Conclusion
Identification of the ‘mothball-like’ odour associated with amitraz 
poisoning in severely ill patients should prompt vigorous resuscitation 
and support, with attention to respiration, blood pressure and glucose 
control. 
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